Dergiler / Turkish Journal of Chemistry / 2020 / Cilt: 44 - Sayı: 6

Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives

Sayfa
1674–1693
Yayın Tarihi
2022-11-04
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

As a result, this study provides interesting data which can be used to design new taurine-based anticancer derivatives.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:In this study, a group of 4-substituted benzoyltaurinamide derivatives were designed, synthesized, and investigated for their anticancer activity against three cancer cell lines and one nontumorigenic cell line by MTT assay.
📊
Temel Bulgular & Veri:Among the final compounds, methoxyphenyl derivatives 14, 15, 16 were found to be effective against all the tested cancerous cell lines with promising selectivity.
💡
Sonuç & Katkı:As a result, this study provides interesting data which can be used to design new taurine-based anticancer derivatives.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

In this study, a group of 4-substituted benzoyltaurinamide derivatives were designed, synthesized, and investigated for their anticancer activity against three cancer cell lines and one nontumorigenic cell line by MTT assay. Among the final compounds, methoxyphenyl derivatives 14, 15, 16 were found to be effective against all the tested cancerous cell lines with promising selectivity. The most active compounds were further evaluated to determine the molecular mechanism of their anticancer activity by using western blot assay and the Annexin V-FITC/PI test. Compound 14 (in SH-SY5Y and MDA-MB-231 cell lines) and 15 (in SH-SY5Y cell line) were found to induce intrinsic apoptotic pathway by upregulating BAX, caspase-3, and caspase-9, while downregulating Bcl-2 and Bcl-xL expression levels. According to mechanistic studies, compounds displayed their anticancer activity via three different mechanisms: a. caspase-dependent, b. caspase-independent, and c. caspase-dependent pathway that excluded caspase-9 activation. As a result, this study provides interesting data which can be used to design new taurine-based anticancer derivatives.

🔖

Bu Makaleye Atıf Yap

GÜNDÜZ, C., KAYABAŞI, Ç., AKGÜL, Ö., ERDOĞAN, M. A., ARMAĞAN, G., BİRİM, D. (2022). Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives. Turkish Journal of Chemistry, Cilt: 44 - Sayı: 6, 1674–1693. https://ajindex.com/articles/601616

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018; 68: 394-424
  2. Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: A brief review. Advanced Pharmaceutical Bulletin 2017; 7: 339-348
  3. Narang AS, Desai DS. Anticancer drug development unique aspects of pharmaceutical development. In: Lu Y, Mahato RI (editors). Pharmaceutical Perspectives of Cancer Therapeutics. New York, NY, USA: Springer, 2009: 49-92
  4. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674
  5. Kiraz Y, Adan A, Kartal Yandim M, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biology 2016; 37: 8471- 8486
  6. Ichim G, Tait SWG. A fate worse than death: Apoptosis as an oncogenic process. Nature Reviews Cancer 2016; 16: 539-548
  7. Bai L, Chen J, McEachern D, Liu L, Zhou H et al. BM-1197: A novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and longlasting tumor regression in vivo. PLoS ONE 2014; 9: e99404
  8. Roth SH, Hergenrother JP. Derivatives of procaspase-activating compound 1 (PAC-1) and their anticancer activities. Current Medicinal Chemistry 2016; 23: 201-241
  9. Chen K, Zhang Q, Wang J, Liu F, Mi M et al. Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Research 2009; 1279: 131-138
  10. Vanitha MK, Baskaran K, Periyasamy K, Saravanan D, Ilakkia A et al. A review on the biomedical importance of taurine. International Journal of Pharma Research and Health Sciences 2015; 3: 680-686
  11. Zhang X, Tu S, Wang Y, Xu B, Wan F. Mechanism of taurine-induced apoptosis in human colon cancer cells. Acta Biochimica et Biophysica Sinica 2014; 46: 261-272
  12. Tu S, Zhang X, Wan H, Xia Y, Liu Z et al. Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells. Oncology Letters 2018; 15: 5473-5480
  13. Srivastava S, Roy R, Singh S, Kumarb P, Dalela D et al. Taurine - a possible fingerprint biomarker in non-muscle invasive bladder cancer: a pilot study by 1H NMR spectroscopy. Cancer Biomarkers 2009; 6: 11-20
  14. El Agouza IM, Eissa SS, El Houseini MM, El-Nashar DE, Abd El Hameed OM. Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients. Angiogenesis 2011